Skip to main content
. 2020 Aug 1;9(16):e015593. doi: 10.1161/JAHA.119.015593

Table 4.

Change in Optical Coherence Tomography Findings

Control Group (n=31) EPA Group (n=31) EPA+DHA Group (n=35)
Baseline Follow‐Up P Value Baseline Follow‐Up P Value Baseline Follow‐Up P Value
Minimal FCT, μm 130 (70–190) 160 (100–250) 0.0121 120 (70–160) 150 (120–210) 0.0029 100 (60–150) 200 (130–260) <0.0001
Maximal lipid arc, ° 202.5 (162.2–234.4) 165.9 (137.9–196.9) 0.0003 176.9 (149.5–247.3) 159.0 (121.1–241.4) 0.0079 175.2 (138.4–218.2) 157.9 (127.2–213.4) 0.0141
Average lipid arc, ° 152.0 (125.5–164.3) 144.4 (127.6–171.3) 0.4790 150.9 (121.6–185.7) 153.7 (113.3–207.6) 0.9522 147.6 (122.2–195.1) 134.0 (103.9–183.7) 0.9522
Lipid length, mm 4.6 (2.8–7.4) 4.4 (2.8–7.0) 0.5440 4.2 (2.4–5.6) 3.6 (2.4–5.0) 0.0016 3.4 (2.2–5.6) 2.8 (2.0–4.4) 0.0107
Lipid volume index 766.0 (435.2–1148.8) 723.8 (360.4–1017.0) 0.5051 626.6 (462.4–932.6) 558.9 (317.2–835.6) 0.0484 462.1 (355.7–876.8) 384.2 (225.1–735.4) 0.0119
Macrophage infiltration 28 (90) 27 (87) 0.5722 27 (87) 25 (81) 0.1607 33 (94) 30 (86) 0.083
Cholesterol crystal 8 (26) 8 (26) 1.000 3 (10) 1 (3)*, * 0.1607 6 (17) 6 (17) 1.000
Microchannel 6 (19) 6 (19) 1.000 5 (16) 4 (13) 0.3253 6 (17) 6 (17) 1.000
Plaque rupture 3 (10) 3 (10) 1.000 1 (3) 1 (3) 1.000 0 (0) 0 (0) 1.000

Values are presented as median (interquartile interval) or n (percentage). DHA indicates docosahexaenoic acid; EPA, eicosapentaenoic acid; and FCT, fibrous cap thickness.

*

P<0.05 vs control group at follow‐up.